Corriente Advisors’s Viracta Therapeutics VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-86,334
Closed -$1.25M – 18
2020
Q1
$1.25M Buy
+86,334
New +$1.87M 1.35% 10

Other funds holding VIRX

Corriente Advisors's VIRX Position: Q2 2020 in Review

Corriente Advisors sold out of Viracta Therapeutics (VIRX) in Q2 2020, closing a stake of 86,334 shares — an estimated $1.25M sold.

Corriente Advisors first reported a position in VIRX in Q1 2020 and held it in 1 quarter. The position peaked at $1.25M in Q1 2020. 41 funds tracked by Wall St. Rank hold VIRX as of Q2 2020.

  • Corriente Advisors reported no remaining Viracta Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Corriente Advisors sold 86,334 Viracta Therapeutics shares in Q2 2020, an estimated $1.25M.
  • Corriente Advisors first reported a position in Viracta Therapeutics in Q1 2020 and held it in 1 quarter.
  • Corriente Advisors's Viracta Therapeutics position peaked at $1.25M in Q1 2020.
  • 41 funds tracked by Wall St. Rank held Viracta Therapeutics as of Q2 2020.

Based on Corriente Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.